Methylergonovine recalls

The FDA has published 3 recalls involving Methylergonovine since 2014. The latest was reported on 1 Jul 2026. Most were for potency & assay. The Harvard Drug Group has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.

Total recalls3since 2014

Last 12 months1reported

Class I00% of total

Ongoing1latest 1 Jul 2026

Recalls per month, last 24 months

click a bar for that month

0Oct '24 0 0 0Jan '25 0 0 0Apr 0 0 0Jul 0 0 0Oct 0 0 0Jan '26 0 0 0Apr 0 0 1Jul 0 0

Severity split

Class I 0 0%Class II 3 100%Class III 0 0%

Why methylergonovine is recalled

Potency & Assay267%
Labeling Errors133%

Companies

By year

2026133%
2024133%
2014133%

Ongoing methylergonovine recalls

1 active

Reported	Class	Recall	Company	Reason	Where
1 Jul 2026Drug	CLASS II	Carton Label: Major, Methylergonovine Maleate Tablets recalledMethylergonovine Maleate	The Harvard Drug Group	Potency & Assay	Nationwide

All methylergonovine recalls, newest first

3 total

Reported	Class	Recall	Company	Reason	Where
1 Jul 2026Drug	CLASS II	Carton Label: Major, Methylergonovine Maleate Tablets recalledMethylergonovine Maleate	The Harvard Drug Group	Potency & Assay	Nationwide
8 May 2024Drug	CLASS II	Methylergonovine Maleate Tablets, USP, 0.2mg recalledMethylergonovine Maleate	Amneal Pharmaceuticals of New York	Potency & Assay	Nationwide
22 Jan 2014Drug	CLASS II	Methylergonovine Maleate Tablet, 0.2 mg recalled by Aidapak Services	Aidapak Services	Labeling Errors	4 states

Should you stop taking Methylergonovine?

Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.